Announced
Completed
Financials
Tags
Acquisition
Biotechnology
United States
Public
advanced materials solutions
Majority
Friendly
Completed
Single Bidder
Synopsis
Merck, a science and technology company, completed the acquisition of Intermolecular, a trusted partner for advanced materials innovation, for $1.20 per share in an all-cash transaction, representing an equity value of Intermolecular of c. $62m. “Today is a very special day for us as we successfully complete the acquisition and welcome Intermolecular to Merck. For three and a half centuries, we have been dedicated to advancing science and technology for the benefit of human progress. I am glad that Intermolecular shares this spirit. Together we are well-positioned to drive and accelerate future innovations in the electronic materials industry,” Kai Beckmann, Merck Member of the Executive Board and Performance Materials CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.